Sarah L Zielinski. Show Affiliations »
Abstract
Mesh: See more » Adverse Drug Reaction Reporting Systems/legislation & jurisprudenceAdverse Drug Reaction Reporting Systems/standardsClinical Trials Data Monitoring CommitteesDrug Approval/legislation & jurisprudenceDrug Industry/legislation & jurisprudenceDrug-Related Side Effects and Adverse ReactionsHumansLegislation, Drug/trendsProduct Surveillance, Postmarketing/methodsProduct Surveillance, Postmarketing/standardsUnited StatesUnited States Food and Drug Administration
Year: 2005 PMID: 15956645 DOI: 10.1093/jnci/97.12.872
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506